Cormorant Asset Management

Cormorant Asset Management as of March 31, 2017

Portfolio Holdings for Cormorant Asset Management

Cormorant Asset Management holds 75 positions in its portfolio as reported in the March 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Theravance Biopharma (TBPH) 7.6 $53M 1.4M 36.82
Nevro (NVRO) 4.8 $33M 350k 93.70
Proteostasis Therapeutics In 4.3 $30M 3.8M 7.82
Galapagos Nv- (GLPG) 3.8 $26M 300k 86.90
Anaptysbio Inc Common (ANAB) 3.6 $25M 896k 27.75
Ardelyx (ARDX) 3.5 $24M 1.9M 12.65
Blueprint Medicines (BPMC) 3.5 $24M 600k 39.99
Aclaris Therapeutics (ACRS) 3.5 $24M 800k 29.82
Portola Pharmaceuticals 3.4 $24M 600k 39.19
Alder Biopharmaceuticals 3.3 $23M 1.1M 20.80
Quotient 2.9 $20M 2.9M 6.99
Minerva Neurosciences 2.7 $19M 2.3M 8.10
Heron Therapeutics (HRTX) 2.6 $18M 1.2M 15.00
Eagle Pharmaceuticals (EGRX) 2.4 $17M 200k 82.94
Clearside Biomedical (CLSD) 2.2 $15M 1.9M 7.94
Myokardia 2.2 $15M 1.1M 13.15
Juno Therapeutics 2.1 $14M 650k 22.19
Corbus Pharmaceuticals Hldgs 2.0 $14M 1.7M 8.25
Wave Life Sciences (WVE) 1.9 $13M 482k 27.50
Coherus Biosciences (CHRS) 1.9 $13M 620k 21.15
Neurocrine Biosciences (NBIX) 1.9 $13M 300k 43.30
Forward Pharma A/s 1.8 $13M 589k 21.55
Omeros Corporation (OMER) 1.6 $11M 750k 15.12
Zynerba Pharmaceuticals 1.5 $10M 500k 20.10
China Biologic Products 1.4 $10M 100k 100.13
Gemphire Therapeutics 1.4 $10M 953k 10.50
Jounce Therapeutics 1.4 $9.6M 435k 21.99
Inc Resh Hldgs Inc cl a 1.3 $9.2M 200k 45.85
Protagonist Therapeutics (PTGX) 1.3 $8.8M 684k 12.81
Fulgent Genetics (FLGT) 1.2 $8.2M 750k 10.92
Array BioPharma 1.2 $8.0M 900k 8.94
Audentes Therapeutics 1.1 $7.2M 425k 17.04
Sorrento Therapeutics (SRNE) 1.0 $6.7M 1.7M 3.95
Rigel Pharmaceuticals 1.0 $6.6M 2.0M 3.31
Contrafect 0.9 $6.4M 3.6M 1.80
Invuity 0.9 $6.0M 757k 7.95
Dex (DXCM) 0.9 $5.9M 70k 84.73
Dermira 0.8 $5.8M 170k 34.11
Curis 0.8 $5.6M 2.0M 2.78
Synergy Pharmaceuticals 0.8 $5.6M 1.2M 4.66
Recro Pharma 0.8 $5.2M 590k 8.74
Ultragenyx Pharmaceutical (RARE) 0.7 $5.1M 75k 67.79
Agenus 0.7 $4.5M 1.2M 3.77
Intec Pharma 0.6 $4.1M 810k 5.11
Agile Therapeutics 0.6 $4.0M 1.3M 3.20
Cytomx Therapeutics (CTMX) 0.6 $4.0M 230k 17.27
Pfenex 0.5 $3.3M 575k 5.81
Syndax Pharmaceuticals (SNDX) 0.5 $3.3M 240k 13.72
Sangamo Biosciences (SGMO) 0.5 $3.1M 600k 5.20
Collegium Pharmaceutical Inc Common Stock Usd (COLL) 0.4 $3.0M 300k 10.06
Advanced Accelerat spon ads each rep 2 ord 0.4 $3.0M 75k 39.87
Lipocine 0.4 $2.9M 742k 3.90
Ascendis Pharma A S (ASND) 0.4 $2.8M 100k 28.00
Oncobiologics 0.4 $2.7M 1.0M 2.68
Epizyme 0.3 $2.4M 140k 17.15
Regenxbio Inc equity us cm (RGNX) 0.3 $2.3M 120k 19.30
Immune Design 0.3 $2.3M 337k 6.80
Avexis 0.3 $2.3M 30k 76.03
Sunesis Pharmaceuticals Inc Ne 0.3 $2.1M 520k 4.10
Acceleron Pharma 0.3 $2.0M 75k 26.47
Abeona Therapeutics 0.3 $2.0M 400k 5.00
Tigenix 0.3 $2.0M 129k 15.60
Xencor (XNCR) 0.3 $1.8M 75k 23.92
Corvus Pharmaceuticals (CRVS) 0.2 $1.7M 81k 20.77
Glycomimetics (GLYC) 0.2 $1.6M 287k 5.43
Htg Molecular Diagnostics 0.2 $1.4M 204k 6.92
Myovant Sciences 0.2 $1.2M 100k 11.74
Aptose Biosciences 0.1 $1.0M 991k 1.02
Threshold Pharmaceuticals 0.1 $513k 900k 0.57
AVEO Pharmaceuticals 0.1 $413k 700k 0.59
Neos Therapeutics 0.1 $364k 51k 7.19
Oncobiologics Inc *w exp 02/18/201 0.1 $333k 417k 0.80
Oncobiologics Inc *w exp 05/18/201 0.0 $208k 417k 0.50
Cellectar Biosciences 0.0 $122k 54k 2.27
Cellectar Biosciences Equity Warrants *w 0.0 $20k 53k 0.38